Skip to content
Reipet – Lifestyle
Author:
CORE Biomedicine
CORE Biomedicine Signs Exclusive Licensing Agreement with Eisai for Precision Oncology Programs
July 28, 2026
CORE Biomedicine Secures $21 Million Series A Venture Financing and Receives AMED Grant Award to Advance Novel Cancer Therapeutics
July 28, 2026